Literature DB >> 7506511

Antiviral action of trehalose dimycolate against EMC virus: role of macrophages and interferon alpha/beta.

E Guillemard1, M Geniteau-Legendre, B Mabboux, I Poilane, R Kergot, G Lemaire, J F Petit, C Labarre, A M Quero.   

Abstract

Preventive treatment of mice with trehalose 6,6' dimycolate (TDM), an immunomodulator of bacterial origin, enhances their resistance to encephalomyocarditis (EMC) virus infection. The protective effect of TDM is totally abolished by the injection of silica particles in mice, demonstrating the role of macrophages in the antiviral action of TDM. In vitro, peritoneal macrophages from mice treated with TDM (TDM-PM) exhibit an intrinsic antiviral activity against EMC virus, while resident peritoneal macrophages (RES-PM) are permissive to this virus. Greater amounts of interferon are detected in supernatants of cultures of TDM-PM than of RES-PM. Neutralization of interferon (IFN) by addition in vitro of anti-IFN alpha/beta serum markedly reduces the antiviral activity of TDM-PM. These results indicate that interferon alpha/beta is involved in the intrinsic anti-EMC virus activity of peritoneal macrophages from mice treated with TDM.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506511     DOI: 10.1016/0166-3542(93)90096-2

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  3 in total

1.  Inhibitory activity of constitutive nitric oxide on the expression of alpha/beta interferon genes in murine peritoneal macrophages.

Authors:  E Guillemard; B Varano; F Belardelli; A M Quero; S Gessani
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Interleukin-12 synthesis is a required step in trehalose dimycolate-induced activation of mouse peritoneal macrophages.

Authors:  I P Oswald; C M Dozois; J F Petit; G Lemaire
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

3.  Activity of nitric oxide-generating compounds against encephalomyocarditis virus.

Authors:  E Guillemard; M Geniteau-Legendre; R Kergot; G Lemaire; J F Petit; C Labarre; A M Quero
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.